PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.
PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.
PharmGKB contains no clinical annotations for this gene. To report clinical variants, click here.
PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.
Overview
| Alternate Names: | UBC7 homolog, yeast; human ubiquitin conjugating enzyme G2; ubiquitin carrier protein G2; ubiquitin conjugating enzyme 7; ubiquitin conjugating enzyme G2; ubiquitin-conjugating enzyme E2 G2; ubiquitin-conjugating enzyme E2G 2; ubiquitin-conjugating enzyme E2G 2 (homologous to yeast UBC7); ubiquitin-protein ligase G2 |
|---|---|
| Alternate Symbols: | UBC7 |
| PharmGKB Accession Id: | PA37132 |
Details
| Cytogenetic Location: | chr21 : q22.3 - q22.3 |
|---|---|
| GP mRNA Boundary†: | chr21 : 46188955 - 46221738 |
| GP Gene Boundary†: | chr21 : 46185955 - 46231738 |
| Strand: | minus |
| Product Name: | No data available |
PharmGKB Curated Pathways
Pathways created internally by PharmGKB based primarily on literature evidence.
PharmGKB contains no curated pathways for this gene. If you would like to volunteer to work on a pathway, please let us know.
External Pathways
Links to non-PharmGKB pathways.
Publications related to UBE2G2: 2
|
Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation. Pharmacogenetics and genomics. 2008. Li Fang, et al. [Article:18820593@PubMed] |
|
|
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer cell. 2002. Yeoh Eng-Juh, et al. [Article:12086872@PubMed] |
LinkOuts
- UniProtKB:
- A6NMQ7_HUMAN (A6NMQ7)
- UB2G2_HUMAN (P60604)
- Ensembl:
- ENSG00000184787
- GenAtlas:
- UBE2G2
- GeneCard:
- GC21M046188 (7327)
- MutDB:
- UBE2G2
- ALFRED:
- LO006858B